| Literature DB >> 33853576 |
Ziyang Liu1, Tie Liu1, Yong Hai2, Lingyun Wu3, Junrui Jonathan Hai4, Kang Gao5, Xuanrong Guo6, Honghao Yang1, Nan Kang1, Fan Zhao1.
Abstract
BACKGROUND: Obtaining and maintaining final shoulder balance after the entire treatment course is essential for early-onset scoliosis (EOS) patients. The relatively small number of growing-rod (GR) graduates who complete final fusion has resulted in an overall paucity of research on the GR treatment of EOS and a lack of research on the shoulder balance of EOS patients during GR treatment.Entities:
Keywords: Early-onset scoliosis; Growing rod; Postoperative shoulder imbalance; Shoulder balance; Spinal fusion
Year: 2021 PMID: 33853576 PMCID: PMC8045187 DOI: 10.1186/s12891-021-04221-9
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Demographics
| Descriptive items | Mean ± SD or Number (%) |
|---|---|
| Sex | |
| Male | 6 (25.0%) |
| Female | 18 (75.0%) |
| Diagnosis | |
| Idiopathic | 10 (41.7%) |
| Congenital | 9 (37.5%) |
| Other | 5 (20.8%) |
| Age (implantation) (year) | 9.8 ± 2.3 |
| Age (fusion) (year) | 13.0 ± 1.5 |
| Risser sign (implantation) (0/1) | |
| 0 | 21 (87.5%) |
| 1 | 3 (12.5%) |
| Risser sign (fusion) (4/5) | |
| 4 | 4 (16.7%) |
| 5 | 20 (83.3%) |
| Treatment duration (year) | 3.2 ± 1.4 |
| No. of lengthening surgeries | 2.5 ± 1.5 |
| Implantation rod(s) | |
| Single | 19 (79.2%) |
| Dual | 5 (20.8%) |
| UIV (Growing rods) | |
| T2 and above | 16 (66.7%) |
| T3 and below | 8 (33.3%) |
| UIV (Fusion) | |
| T2 and above | 14 (58.3%) |
| T3 and below | 10 (41.7%) |
| LIV (Growing rods) | |
| L3 and above | 10 (41.7%) |
| L4 and below | 14 (58.3%) |
| LIV (Fusion) | |
| L3 and above | 17 (70.8%) |
| L4 and below | 7 (29.2%) |
| Upper instrument (Growing rods) | |
| Hook/hybrid | 16 (66.7%) |
| No hook | 8 (33.3%) |
| Upper instrument (Fusion) | |
| Hook/hybrid | 5 (20.8%) |
| No hook | 19 (79.2%) |
UIV upper instrumented vertebrae; LIV lower instrumented vertebrae
Radiographic parameters from preimplantation to final follow-up for the entire study population
| MC (°) | PTC (°) | TK (°) | LL (°) | C7PL-CSVL (cm) | C7PL-SVA (cm) | |
|---|---|---|---|---|---|---|
| Preimplantation | 96 ± 22 | 43 ± 18 | 47 ± 24 | 48 ± 14 | 3.0 ± 2.6 | 3.0 ± 2.0 |
| Postimplantation | 51 ± 20 | 30 ± 13 | 33 ± 15 | 41 ± 14 | 2.4 ± 1.8 | 3.2 ± 1.8 |
| Prefusion | 59 ± 20 | 30 ± 12 | 41 ± 15 | 57 ± 14 | 2.4 ± 1.7 | 2.7 ± 2.1 |
| Follow-up | 38 ± 17 | 21 ± 8 | 35 ± 12 | 52 ± 12 | 2.7 ± 1.6 | 3.2 ± 2.3 |
MC major curve; PTC proximal thoracic curve; TK thoracic kyphosis; LL lumbar lordosis; C7PL cervical 7 plumb line; CSVL centre sacral vertical line; SVA sagittal vertebral axis
Fig. 1Changes in the radiographic shoulder balance of EOS patients throughout the entire growing rod treatment period. a RSH (b) CA (c) T1T.*Statistically significant. +: mean value. ●: extreme values
Fig. 2Number of patients with different shoulder balance statuses during the growing rod treatment period
Fig. 3Comparison of the final RSH between patients grouped by shoulder balance status at preimplantation, postimplantation, prefusion, and early postfusion. Grey bar: shoulder imbalance group. White bar: shoulder balance group. *Statistically significant. +: mean value. ●■: extreme values
Fig. 4Changes in the RSH of patients in the shoulder balance group and shoulder imbalance group. Patients grouped at (a) postimplantation and (b) prefusion. Grey bar: shoulder imbalance group. White bar: shoulder balance group. *Statistically significant differences between groups (**P < 0.001). #Statistically significant improvement in the group. +: mean value. ●■: extreme values
Univariate analysis of shoulder imbalance risk factors
| Parameters | Balanced shoulder | Imbalanced shoulder | |
|---|---|---|---|
| Demographics | |||
| Sex (male/female) | 4/13 | 2/5 | 1.000 |
| Diagnosis (congenital/not) | 5/12 | 4/3 | 0.356 |
| Age at implantation | 9.3 ± 2.3 | 11.0 ± 1.6 | |
| Age at fusion | 12.7 ± 1.5 | 13.9 ± 1.2 | |
| Risser sign at implantation (0/1) | 15/2 | 6/1 | 1.000 |
| Risser sign at fusion (4/5) | 3/14 | 1/6 | 1.000 |
| Treatment duration (y) | 3.4 ± 1.6 | 2.8 ± 1.0 | 0.429 |
| Left/right curve | 4/13 | 3/4 | 0.374 |
| Surgery-related | |||
| No. of lengthening surgeries | 2.5 ± 1.7 | 2.4 ± 1.0 | 0.885 |
| Single/dual rod(s) | |||
| Implantation | 13/4 | 6/1 | 1.000 |
| Prefusion | 8/9 | 5/2 | 0.386 |
| UIV(T2 and above/T3 and below) | |||
| Growing rods | 12/5 | 4/3 | 0.647 |
| Fusion | 12/5 | 2/5 | |
| LIV(L3 and above/L4 and below) | |||
| Growing rods | 8/9 | 2/5 | 0.653 |
| Fusion | 12/5 | 5/2 | 1.000 |
| Upper instrument (hook or hybrid/no hook) | |||
| Growing rods | 11/6 | 5/2 | 1.000 |
| Fusion | 3/14 | 2/5 | 0.608 |
| Fixation of the apical region/not at fusion | 11/6 | 3/4 | 0.393 |
| Osteotomy/not at fusion | 3/14 | 2/5 | 0.608 |
| Radiographic | |||
| MC Cobb angle (°) | |||
| Preimplantation | 98 ± 20 | 93 ± 26 | 0.637 |
| Postimplantation | 53 ± 18 | 45 ± 26 | 0.359 |
| Prefusion | 60 ± 19 | 57 ± 24 | 0.756 |
| Follow-up | 41 ± 17 | 32 ± 18 | 0.252 |
| Change | 57 ± 12 | 61 ± 17 | 0.506 |
| PTC Cobb angle (°) | |||
| Preimplantation | 44 ± 20 | 42 ± 15 | 0.815 |
| Postimplantation | 30 ± 14 | 29 ± 10 | 0.947 |
| Prefusion | 30 ± 14 | 30 ± 9 | 0.890 |
| Follow-up | 21 ± 8 | 21 ± 6 | 0.895 |
| Change | 22 ± 14 | 21 ± 13 | 0.887 |
| Flexibility (preimplantation) | |||
| PTC | 38 ± 27 | 29 ± 12 | 0.433 |
| MC | 19 ± 17 | 19 ± 15 | 0.976 |
| Thoracic kyphosis | |||
| Preimplantation | 46 ± 25 | 52 ± 25 | 0.575 |
| Postimplantation | 34 ± 15 | 31 ± 17 | 0.689 |
| Prefusion | 39 ± 15 | 47 ± 12 | 0.239 |
| Follow-up | 33 ± 12 | 39 ± 12 | 0.272 |
| Change | 13 ± 22 | 13 ± 19 | 0.983 |
| Lumbar lordosis | |||
| Preimplantation | 48 ± 15 | 48 ± 14 | 0.980 |
| Postimplantation | 40 ± 13 | 44 ± 16 | 0.511 |
| Prefusion | 56 ± 14 | 61 ± 13 | 0.384 |
| Follow-up | 53 ± 10 | 52 ± 16 | 0.888 |
| Change | −5 ± 18 | −4 ± 17 | 0.955 |
| C7PL-CSVL (cm) | |||
| Preimplantation | 3.1 ± 2.4 | 3.0 ± 3.2 | 0.936 |
| Postimplantation | 2.4 ± 1.6 | 2.5 ± 2.4 | 0.896 |
| Prefusion | 2.5 ± 1.6 | 2.1 ± 1.8 | 0.559 |
| Follow-up | 2.9 ± 1.6 | 2.2 ± 1.7 | 0.392 |
| Change | 0.2 ± 3.4 | 0.8 ± 3.0 | 0.699 |
| C7PL-SVA (cm) | |||
| Preimplantation | 2.7 ± 2.0 | 3.7 ± 2.0 | 0.303 |
| Postimplantation | 3.3 ± 1.9 | 2.9 ± 1.4 | 0.641 |
| Prefusion | 2.2 ± 1.8 | 3.9 ± 2.5 | |
| Follow-up | 3.0 ± 2.4 | 3.5 ± 2.0 | 0.685 |
| Change | −0.3 ± 3.2 | 0.2 ± 2.6 | 0.722 |
| Shoulder Balance | |||
| RSH (mm) | |||
| Preimplantation | 23.7 ± 16.1 | 24.2 ± 16.9 | 0.942 |
| Postimplantation | 16.7 ± 5.9 | 18.1 ± 13.8 | 0.807 |
| Prelengthening | 18.6 ± 10.2 | 16.7 ± 9.1 | 0.680 |
| Postlengthening | 18.4 ± 13.6 | 16.9 ± 6.7 | 0.792 |
| Prefusion | 18.3 ± 11.8 | 19.5 ± 9.8 | 0.806 |
| Postfusion | 12.5 ± 6.4 | 25.8 ± 9.5 | |
| Follow-up | 7.3 ± 4.0 | 27.5 ± 7.7 | |
RSB classification (balanced/unbalanced) | |||
| Preimplantation | 7/10 | 4/3 | 0.659 |
| Postimplantation | 10/7 | 4/3 | 1.000 |
| Prelengthening | 9/8 | 5/2 | 0.653 |
| Postlengthening | 11/6 | 5/2 | 1.000 |
| Prefusion | 9/8 | 2/5 | 0.386 |
| Postfusion | 13/4 | 1/6 | |
| Follow-up | 17/0 | 0/7 | |
| Other Parameters | |||
| CA (°) | |||
| Preimplantation | 6.8 ± 4.2 | 5.1 ± 4.2 | 0.392 |
| Postimplantation | 4.0 ± 2.9 | 3.6 ± 4.2 | 0.814 |
| Prefusion | 3.8 ± 2.0 | 3.3 ± 1.3 | 0.926 |
| Postfusion | 3.4 ± 2.7 | 5.8 ± 3.3 | |
| Follow-up | 1.9 ± 0.9 | 4.3 ± 2.6 | |
| T1T (°) | |||
| Preimplantation | 18.8 ± 15.9 | 17.9 ± 15.1 | 0.900 |
| Postimplantation | 12.7 ± 10.5 | 13.6 ± 11.8 | 0.846 |
| Prefusion | 16.1 ± 13.1 | 14.9 ± 9.5 | 0.822 |
| Postfusion | 15.0 ± 15.1 | 19.3 ± 13.5 | 0.523 |
| Follow-up | 11.3 ± 11.8 | 16.5 ± 7.2 | 0.295 |
RSH radiographic shoulder height; RSB radiographic shoulder balance; UIV upper instrumented vertebrae; LIV lower instrumented vertebrae; C7PL cervical 7 plumb line; CSVL centre sacral vertical line; SVA sagittal vertebral axis; MC major curve; PTC,proximal thoracic curve
Bold numbers indicate P<0.10